Neko Health Raises $700M Series C to Bring AI-Powered Preventive Scanning to the US

Source: Axios — 2026-07-15

Summary

Neko Health, the body-scanning preventive health startup co-founded by Spotify CEO Daniel Ek and CEO Hjalmar Nilsonne, raised a $700 million Series C round at a valuation of nearly $7 billion. The round was led by Lightspeed Venture Partners and O.G. Venture Partners, with participation from existing backers including Atomico, General Catalyst, Lakestar, and BDT & MSD. The funding will support Neko's first entry into the US market, with initial clinics planned for New York and other cities, alongside continued investment in its scanning technology.

Key Takeaways

• Neko Health raised $700 million in a Series C round led by Lightspeed Venture Partners and O.G. Venture Partners, with Atomico, General Catalyst, Lakestar, and BDT & MSD also participating.
• The round values the company at nearly $7 billion, roughly four times its $1.7 billion valuation from its $260 million Series B in January 2025.
• The Neko Health Scan is a 60-minute, non-invasive, radiation-free assessment capturing millions of data points, covering skin health (moles and marks), blood abnormalities, pre-diabetes risk, and factors tied to metabolic syndrome, stroke, and heart attack.
• The capital will fund the company's first US clinics, starting in New York, marking its expansion beyond existing locations in the UK and Sweden.
• CEO Hjalmar Nilsonne said the round is "a strong vote of confidence" in Neko's mission to "keep people healthy, catch problems early and help prevent disease before it even starts," and that the company is "taking that mission to the US for the first time."
• The Neko Health Scan currently costs £299 in the UK and 2,750 SEK in Sweden.

Discussion

(No questions yet — ask follow-ups via a Claude Code chat session on this repo; answers get appended here.)